Following an inspection of the Bharat Biotech premises on 14 March for Covaxin's EUL, WHO announced the suspension of the vaccine's supply owing to deficiencies in good manufacturing practices
Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker
Booster dose of vaccine, COVAXIN® (BBV152), generated robust neutralizing antibody responses against both Omicron (B.1.529) and Delta (B.1.617.2) using a live virus neutralization assay
100% of test serum samples showed neutralization of the Delta variant and more than 90% of serum samples showed neutralization
More than 40 lakh teenagers in the 15-18 age group received their first dose of Covid-19 vaccines on Monday as India began its drive to vaccinate the younger population groups. Some concerns were raised about ‘expired’ Covaxin being administered to this younger group, leading to
The first pilot study from India analyzing COVAXIN – COVISHEILD mixed doses
The third COVID-wave led by the Omicron variant has started in India. Although the initial data indicates that this wave will be milder than the previous Delta one with less hospitalization, still a large
According to the sources, Bharat Biotech which has completed the Phase 2/3 trials of Covid-19 vaccine Covaxin for use in children under 18 years of age has submitted the data to the Central Drugs Standard Control Organisation for its verification and subsequent approval for Emergency Use Authorisation
In a study of 614 fully vaccinated health workers in India discovered a "significant" drop in their COVID-fighting antibodies within four months of the first shot.
This findings might help the Indian government to decide whether to provide booster doses. Some of the Western countries have done.
Covid-19 in India may be entering some kind of stage of endemicity where there is low or moderate level of transmission going on, Chief Scientist of the World Health Organisation Dr Soumya Swaminathan said.
The endemic stage is when a population learns to live with a
Union health minister Mansukh Mandaviya on Thursday said the government has launched an inquiry into a report claiming that counterfeit versions of Covishield, India’s primary anti-COVID-19 vaccine, had been seized.
“It has been claimed that duplicate versions of Covishield vaccine were sold in the country. The
India has done better than any country in the world as regards to affordability and the reach to the people of COVID-19 vaccines, Bharat Biotech Chairman and Managing Director Krishna Ella said on Sunday.
Highlighting the enormity of the task of vaccination, Ella said, “When you
Covaxin, Bharat Biotech’s Covid 19 vaccine works with the new Delta variant of the virus, finds a new study published by the Indian Council of Medical Research. In medical lingo, the Delta variant is referred to as B.1.617.2. Not only is it highly contagious, but